On January 2, 2024, the Ministry of Health issued Decision No. 04/QD-BYT regarding the designation of units for assessment of the Common Technical Dossier on medical devices according to the ASEAN regulations.
The decision includes:
1. Designation of units responsible for assessment of the Common Technical Dossier by the ASEAN regulations:
- For documentation related to the issuance of circulation numbers for medical devices that are not in vitro diagnostic medical devices: Institute of Medical Device and Health Works.
- For documentation related to the issuance of circulation numbers for in vitro diagnostic medical devices: National Testing Institute for Vaccine and Medical Biologicals.
2. Valid date of the Decision: January 2, 2024.
1. This Circular elaborates Decree No. 98/2021/ND-CP dated November 8, 2021 of the Government on management of medical devices (hereinafter referred to as “Decree No. 98/2021/ND-CP”).
a) Classification of medical devices under Clause 5 Article 5 of Decree No. 98/2021/ND-CP;
b) Addition to the list of in vitro diagnostic medical devices that are not required to undergo quality inspection by Vietnam’s competent authorities under Point dd Clause 3 Article 30 of Decree No. 98/2021/ND-CP;
c) List of class B, class C, and class D medical devices purchased and sold as common commodities mentioned under Clause 1 Article 42 of Decree No. 98/2021/ND-CP;
d) List of medical devices to be inspected for safety and technical functions under Clause 10 Article 70 of Decree No. 98/2021/ND-CP;
dd) List of medical devices to be granted import permit under Point d Clause 2 Article 76 of Decree No. 98/2021/ND-CP.
2. Annuls documents on management of medical devices.
Circular 10/2023/TT-BYT, issued May 11, 2023: Amendments to Article 3 of Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health on templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices
This Circular provides for emergency marketing authorization of COVID-19 vaccines (hereinafter referred to as “vaccines"), specifically:
1. Applications and procedures for vaccine marketing authorization issuance, renewal and amendment.
2. Requirements for clinical data in applications to ensure vaccine safety and effectiveness.
3. Exemption from one or more than one clinical trial phase and vaccines required to undergo phase 4 clinical trial in Vietnam.
Circular 23/2021/TT-BYT , issued December 09, 2021: Amendments to some legislative documents on medical equipment, pharmacy and population issued by the Minister of Health
On March 3, 2023, the Government issued Decree 07/2023/ND-CP amending Decree 98/2021/ND-CP on medical equipment management.
Accordingly, the content of medical equipment price listing is regulated as follows:
- Organizations and individuals producing and trading medical equipment shall list prices of medical equipment at locations as prescribed in Article 17 of Decree 177/2013/ND-CP guiding the Price Law or on the Electronic Information Portal of the Ministry of Health.
- In case of listing medical equipment prices on the Ministry of Health's Electronic Information Portal, the following minimum information must be included:
+ Name and type of medical equipment.
+ Manufacturing company and country; firm, owner country.
+ Unit of calculation.
+ Configuration and technical features of medical equipment.
+ Listed price of medical equipment.
1. This Circular provides for:
a) Documentation requirements, procedures for issuance, renewal, revision and revocation of the marketing authorization of modern medicines, vaccines, biologicals, herbal drugs and medicinal materials (including active ingredients, semi-finished herbal ingredients, excipients, and capsule shells) for human use in Vietnam;
b) Required clinical data for assurance of safety and efficacy in the application;
c) Requirements for exemption from clinical trial or certain stages thereof in Vietnam; drugs that have to undergo Stage 4 clinical trial;
d) Rules for validation of marketing authorization applications (hereinafter referred to as “marketing application”) for drugs/medicinal materials, renewal and revision thereof;
đ) Rules for validation of applications for license to import drugs that are yet to be approved for marketing authorization (hereinafter referred to as “unapproved drugs”) in the cases specified in Point a Clause 43 Article 5 of Decree No. 155/2018/ND-CP dated November 12, 2018 providing amendments to regulations on business conditions under state management of the Ministry of Health of Vietnam (hereinafter referred to as “Decree No. 155/2018/ND-CP”);
e) Rules for organization and operation of Marketing Authorization Advisory Board (hereinafter referred to as “the Advisory Board”);
g) Procedures for validation of marketing applications, renewal and revision thereof; Procedures for validation of applications for the license to import unapproved drugs.
10 outstanding events in the healthcare industry in 2023.pdfraufkhalid104
The Secretariat and the National Assembly issue Directives and Resolutions to continue consolidating, perfecting and improving the quality of grassroots healthcare operations in the new situation
After 20 years of implementing Directive No. 06-CT/TW dated January 22, 2002 of the IX Party Central Committee Secretariat on consolidating and perfecting the grassroots medical network and Conclusion Notice No. 126-TB/ Central dated April 1, 2013 of the XI Secretariat on 10 years of implementing Directive No. 06-CT/TW, grassroots health activities have achieved important results in primary health care , participating in health insurance medical examination and treatment, disease prevention and control, expanded vaccination... Grassroots medical network covers the entire country, with enhanced facilities, equipment, Human...
This Decree regulates the management of medical equipment, including: classification of medical equipment;
production, clinical research, circulation, purchase and sale, export, import, and service provision of medical equipment;
information, advertising medical equipment; price management of medical equipment and management and use of
medical equipment at medical facilities.
2 . This Decree does not apply to:
a ) Raw materials and semi-finished products for the production of medical equipment, except raw materials
containing narcotics and precursors;
b ) Raw materials for production of medical equipment are samples of blood, serum, plasma, urine, feces, human
body secretions, and other samples from humans, which must ensure biosafety when imported or exported. according to
regulations of the Law;
c ) Medical gas;
d ) Accessories used with medical equipment;
dd) Products used in medicine for research purposes (Research Use Only - RUO), products used in laboratories
(Laboratory Use Only - LUO).
This Decree regulates the management of medical equipment, including: classification of medical equipment;
production, clinical research, circulation, purchase and sale, export, import, and service provision of medical equipment;
information, advertising medical equipment; price management of medical equipment and management and use of
medical equipment at medical facilities.
2 . This Decree does not apply to:
a ) Raw materials and semi-finished products for the production of medical equipment, except raw materials
containing narcotics and precursors;
b ) Raw materials for production of medical equipment are samples of blood, serum, plasma, urine, feces, human
body secretions, and other samples from humans, which must ensure biosafety when imported or exported. according to
regulations of the Law;
c ) Medical gas;
d ) Accessories used with medical equipment;
dd) Products used in medicine for research purposes (Research Use Only - RUO), products used in laboratories
(Laboratory Use Only - LUO).
1. This Circular elaborates Decree No. 98/2021/ND-CP dated November 8, 2021 of the Government on management of medical devices (hereinafter referred to as “Decree No. 98/2021/ND-CP”).
a) Classification of medical devices under Clause 5 Article 5 of Decree No. 98/2021/ND-CP;
b) Addition to the list of in vitro diagnostic medical devices that are not required to undergo quality inspection by Vietnam’s competent authorities under Point dd Clause 3 Article 30 of Decree No. 98/2021/ND-CP;
c) List of class B, class C, and class D medical devices purchased and sold as common commodities mentioned under Clause 1 Article 42 of Decree No. 98/2021/ND-CP;
d) List of medical devices to be inspected for safety and technical functions under Clause 10 Article 70 of Decree No. 98/2021/ND-CP;
dd) List of medical devices to be granted import permit under Point d Clause 2 Article 76 of Decree No. 98/2021/ND-CP.
2. Annuls documents on management of medical devices.
Circular 10/2023/TT-BYT, issued May 11, 2023: Amendments to Article 3 of Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health on templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices
This Circular provides for emergency marketing authorization of COVID-19 vaccines (hereinafter referred to as “vaccines"), specifically:
1. Applications and procedures for vaccine marketing authorization issuance, renewal and amendment.
2. Requirements for clinical data in applications to ensure vaccine safety and effectiveness.
3. Exemption from one or more than one clinical trial phase and vaccines required to undergo phase 4 clinical trial in Vietnam.
Circular 23/2021/TT-BYT , issued December 09, 2021: Amendments to some legislative documents on medical equipment, pharmacy and population issued by the Minister of Health
On March 3, 2023, the Government issued Decree 07/2023/ND-CP amending Decree 98/2021/ND-CP on medical equipment management.
Accordingly, the content of medical equipment price listing is regulated as follows:
- Organizations and individuals producing and trading medical equipment shall list prices of medical equipment at locations as prescribed in Article 17 of Decree 177/2013/ND-CP guiding the Price Law or on the Electronic Information Portal of the Ministry of Health.
- In case of listing medical equipment prices on the Ministry of Health's Electronic Information Portal, the following minimum information must be included:
+ Name and type of medical equipment.
+ Manufacturing company and country; firm, owner country.
+ Unit of calculation.
+ Configuration and technical features of medical equipment.
+ Listed price of medical equipment.
1. This Circular provides for:
a) Documentation requirements, procedures for issuance, renewal, revision and revocation of the marketing authorization of modern medicines, vaccines, biologicals, herbal drugs and medicinal materials (including active ingredients, semi-finished herbal ingredients, excipients, and capsule shells) for human use in Vietnam;
b) Required clinical data for assurance of safety and efficacy in the application;
c) Requirements for exemption from clinical trial or certain stages thereof in Vietnam; drugs that have to undergo Stage 4 clinical trial;
d) Rules for validation of marketing authorization applications (hereinafter referred to as “marketing application”) for drugs/medicinal materials, renewal and revision thereof;
đ) Rules for validation of applications for license to import drugs that are yet to be approved for marketing authorization (hereinafter referred to as “unapproved drugs”) in the cases specified in Point a Clause 43 Article 5 of Decree No. 155/2018/ND-CP dated November 12, 2018 providing amendments to regulations on business conditions under state management of the Ministry of Health of Vietnam (hereinafter referred to as “Decree No. 155/2018/ND-CP”);
e) Rules for organization and operation of Marketing Authorization Advisory Board (hereinafter referred to as “the Advisory Board”);
g) Procedures for validation of marketing applications, renewal and revision thereof; Procedures for validation of applications for the license to import unapproved drugs.
10 outstanding events in the healthcare industry in 2023.pdfraufkhalid104
The Secretariat and the National Assembly issue Directives and Resolutions to continue consolidating, perfecting and improving the quality of grassroots healthcare operations in the new situation
After 20 years of implementing Directive No. 06-CT/TW dated January 22, 2002 of the IX Party Central Committee Secretariat on consolidating and perfecting the grassroots medical network and Conclusion Notice No. 126-TB/ Central dated April 1, 2013 of the XI Secretariat on 10 years of implementing Directive No. 06-CT/TW, grassroots health activities have achieved important results in primary health care , participating in health insurance medical examination and treatment, disease prevention and control, expanded vaccination... Grassroots medical network covers the entire country, with enhanced facilities, equipment, Human...
This Decree regulates the management of medical equipment, including: classification of medical equipment;
production, clinical research, circulation, purchase and sale, export, import, and service provision of medical equipment;
information, advertising medical equipment; price management of medical equipment and management and use of
medical equipment at medical facilities.
2 . This Decree does not apply to:
a ) Raw materials and semi-finished products for the production of medical equipment, except raw materials
containing narcotics and precursors;
b ) Raw materials for production of medical equipment are samples of blood, serum, plasma, urine, feces, human
body secretions, and other samples from humans, which must ensure biosafety when imported or exported. according to
regulations of the Law;
c ) Medical gas;
d ) Accessories used with medical equipment;
dd) Products used in medicine for research purposes (Research Use Only - RUO), products used in laboratories
(Laboratory Use Only - LUO).
This Decree regulates the management of medical equipment, including: classification of medical equipment;
production, clinical research, circulation, purchase and sale, export, import, and service provision of medical equipment;
information, advertising medical equipment; price management of medical equipment and management and use of
medical equipment at medical facilities.
2 . This Decree does not apply to:
a ) Raw materials and semi-finished products for the production of medical equipment, except raw materials
containing narcotics and precursors;
b ) Raw materials for production of medical equipment are samples of blood, serum, plasma, urine, feces, human
body secretions, and other samples from humans, which must ensure biosafety when imported or exported. according to
regulations of the Law;
c ) Medical gas;
d ) Accessories used with medical equipment;
dd) Products used in medicine for research purposes (Research Use Only - RUO), products used in laboratories
(Laboratory Use Only - LUO).
Circular 03/2020/TT-BYT issued January 22, 2020: Amendments to some Articles of the Circular No. 11/2018/TT-BYT dated May 04, 2018 of the Minister of Health on quality of pharmaceutical products and pharmaceutical starting materials
Decision No. 2426/QD-BYT : Issue together with this Decision the ASEAN Common Submission Dossier Template (CSDT) for medical devices, applied to applications for registration of medical devices of class B, C, D.
This Circular provides for templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices.
- This Circular provides for the activities relating to production, trading, product declaration, labeling and provision of instructions for use of functional foods such as
supplemented foods, health supplements and medical foods, including foods for special dietary uses.
- This Circular does not apply to nutritional formulas for children. Production, trading,
product declaration, labeling and provision of instructions for use of these products shall
comply with corresponding technical regulations and regulations of law on trading and use of nutritional products for children
Recognition of CE certificates on medical devices in Ukraine. Registration pr...Improve Medical LLC
AGENDA:
- How did martial law influence the market of medical devices in Ukraine?
- How is the registration process for medical devices is organized in Ukraine?
- Is it possible to recognize an MDR CE certificate?
1. This Circular regulates the activities related to production, trading, product announcement, labeling and giving instructions on functional foods including supplemented foods, health protection foods, medical foods and foods used for special dietary uses.
2. This Circular does not apply to nutritional formula for children. The production, trading, product announcement, labeling and giving instructions for this product shall be implemented in accordance with corresponding technical regulations and the laws on trading and using nutritional products for children.
1. This Circular prescribes the Nomenclature List of agents prohibited from production and business of health protection food.
2. This Circular shall apply to domestic entities and persons; foreign entities and persons in Vietnam that are involved in production and business of health protection food; entities and persons whose operations relate to health protection food in Vietnam.
This Circular provides for:
1. Principles and requirements of Good Manufacturing Practices (GMP) for health supplements and application of GMP by domestic manufacturers of health supplements.
2. Certificates equivalent to the Certificate of compliance with GMP for imported health supplements.
Medical device management in china and latest regulatory updates_EdwinCIRS China
Currently, China is one of the world's most promising markets for medical devices, which on the back of its vast market size, offers huge potential to medical device companies. All medical devices marketed or sold for use in China must be registered with China Food and Drug Administration (CFDA).
Post-marketing safety surveillance of medical devices and drug-device combina...Arete-Zoe, LLC
ISoP Medical Device SIG Webinar on Post-marketing safety surveillance of medical devices and drug-device combination products
https://isoponline.org/special-interest-groups/medical-devices-group/
PMS is an integral part of a quality management system described in ISO 13485. ISO 13485 references inclusion of applicable regulatory requirements on post market surveillance into the quality management system.
Regulatory requirements are country specific and are continuously evolving. The regulatory processes for devices are significantly different than for drugs. Moreover, the requirements for drug-device combination products are not always clearly articulated.
• In Europe, according to the EU MDR, post-market surveillance shall also allow a comparison to be made between the device and similar products available on the market.
• The first challenge is identifying similar products on the market, that is out of the scope of this webinar. The second challenge is finding relevant information on equivalent and similar products.
• Since EUDAMED does not currently have a post-marketing module, manufacturers have to rely on a large number of national databases. The focus of this webinar is on regulatory requirements in major jurisdictions. There will be another webinar coming soon that will focus on how to obtain the information required to comply with all these requirements.
• With some effort, it is possible to locate information on advisory notices.
• However, adverse events or incidents are not publicly available. This is a major difference from medicinal products.
• In addition, certain AEs are subject to the National Competent Authority Report (NCAR) Exchange. These reports are shared between agencies and can potentially result in FSCA. So even when unable to monitor competitor product adverse event profile, it is important to know about their FSCAs.
Qyết định 166/QD-BYT: Ban hành: “Tiêu chí, nguyên tắc đánh giá Hồ sơ kỹ thuật chung về thiết bị y tế theo quy định của ASEAN (Common Submission Dossier Template - CSDT) đối với thiết bị y tế không phải là thiết bị y tế in vitro”; Nội dung chi tiết tại Phụ lục I, II, III kèm theo Quyết định này
Nghị định này quy định về hành vi vi phạm hành chính, hình thức xử phạt, mức xử phạt, các biện pháp khắc phục hậu quả, thẩm quyền lập biên bản, thẩm quyền xử phạt vi phạm hành chính trong lĩnh vực văn hóa và quảng cáo.
2. Các hành vi vi phạm hành chính trong lĩnh vực văn hóa và quảng cáo không quy định
tại Nghị định này thì áp dụng theo quy định về xử phạt vi phạm hành chính trong các lĩnh
vực quản lý nhà nước có liên quan.
More Related Content
Similar to Decision 04/QĐ-BYT: The Designation of Units for Assessment of The Common Technical Dossier on Medical Devices According to The ASEAN Regulations
Circular 03/2020/TT-BYT issued January 22, 2020: Amendments to some Articles of the Circular No. 11/2018/TT-BYT dated May 04, 2018 of the Minister of Health on quality of pharmaceutical products and pharmaceutical starting materials
Decision No. 2426/QD-BYT : Issue together with this Decision the ASEAN Common Submission Dossier Template (CSDT) for medical devices, applied to applications for registration of medical devices of class B, C, D.
This Circular provides for templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices.
- This Circular provides for the activities relating to production, trading, product declaration, labeling and provision of instructions for use of functional foods such as
supplemented foods, health supplements and medical foods, including foods for special dietary uses.
- This Circular does not apply to nutritional formulas for children. Production, trading,
product declaration, labeling and provision of instructions for use of these products shall
comply with corresponding technical regulations and regulations of law on trading and use of nutritional products for children
Recognition of CE certificates on medical devices in Ukraine. Registration pr...Improve Medical LLC
AGENDA:
- How did martial law influence the market of medical devices in Ukraine?
- How is the registration process for medical devices is organized in Ukraine?
- Is it possible to recognize an MDR CE certificate?
1. This Circular regulates the activities related to production, trading, product announcement, labeling and giving instructions on functional foods including supplemented foods, health protection foods, medical foods and foods used for special dietary uses.
2. This Circular does not apply to nutritional formula for children. The production, trading, product announcement, labeling and giving instructions for this product shall be implemented in accordance with corresponding technical regulations and the laws on trading and using nutritional products for children.
1. This Circular prescribes the Nomenclature List of agents prohibited from production and business of health protection food.
2. This Circular shall apply to domestic entities and persons; foreign entities and persons in Vietnam that are involved in production and business of health protection food; entities and persons whose operations relate to health protection food in Vietnam.
This Circular provides for:
1. Principles and requirements of Good Manufacturing Practices (GMP) for health supplements and application of GMP by domestic manufacturers of health supplements.
2. Certificates equivalent to the Certificate of compliance with GMP for imported health supplements.
Medical device management in china and latest regulatory updates_EdwinCIRS China
Currently, China is one of the world's most promising markets for medical devices, which on the back of its vast market size, offers huge potential to medical device companies. All medical devices marketed or sold for use in China must be registered with China Food and Drug Administration (CFDA).
Post-marketing safety surveillance of medical devices and drug-device combina...Arete-Zoe, LLC
ISoP Medical Device SIG Webinar on Post-marketing safety surveillance of medical devices and drug-device combination products
https://isoponline.org/special-interest-groups/medical-devices-group/
PMS is an integral part of a quality management system described in ISO 13485. ISO 13485 references inclusion of applicable regulatory requirements on post market surveillance into the quality management system.
Regulatory requirements are country specific and are continuously evolving. The regulatory processes for devices are significantly different than for drugs. Moreover, the requirements for drug-device combination products are not always clearly articulated.
• In Europe, according to the EU MDR, post-market surveillance shall also allow a comparison to be made between the device and similar products available on the market.
• The first challenge is identifying similar products on the market, that is out of the scope of this webinar. The second challenge is finding relevant information on equivalent and similar products.
• Since EUDAMED does not currently have a post-marketing module, manufacturers have to rely on a large number of national databases. The focus of this webinar is on regulatory requirements in major jurisdictions. There will be another webinar coming soon that will focus on how to obtain the information required to comply with all these requirements.
• With some effort, it is possible to locate information on advisory notices.
• However, adverse events or incidents are not publicly available. This is a major difference from medicinal products.
• In addition, certain AEs are subject to the National Competent Authority Report (NCAR) Exchange. These reports are shared between agencies and can potentially result in FSCA. So even when unable to monitor competitor product adverse event profile, it is important to know about their FSCAs.
The Commonwealth of Independent States is a regional intergovernmental organisation, formed in 1991
Similar to Decision 04/QĐ-BYT: The Designation of Units for Assessment of The Common Technical Dossier on Medical Devices According to The ASEAN Regulations (20)
Qyết định 166/QD-BYT: Ban hành: “Tiêu chí, nguyên tắc đánh giá Hồ sơ kỹ thuật chung về thiết bị y tế theo quy định của ASEAN (Common Submission Dossier Template - CSDT) đối với thiết bị y tế không phải là thiết bị y tế in vitro”; Nội dung chi tiết tại Phụ lục I, II, III kèm theo Quyết định này
Nghị định này quy định về hành vi vi phạm hành chính, hình thức xử phạt, mức xử phạt, các biện pháp khắc phục hậu quả, thẩm quyền lập biên bản, thẩm quyền xử phạt vi phạm hành chính trong lĩnh vực văn hóa và quảng cáo.
2. Các hành vi vi phạm hành chính trong lĩnh vực văn hóa và quảng cáo không quy định
tại Nghị định này thì áp dụng theo quy định về xử phạt vi phạm hành chính trong các lĩnh
vực quản lý nhà nước có liên quan.
- Thông tư này quy định các hoạt động liên quan đến sản xuất, kinh doanh, công bố sản
phẩm, ghi nhãn và hướng dẫn sử dụng thực phẩm chức năng bao gồm thực phẩm bổ
sung, thực phẩm bảo vệ sức khỏe và thực phẩm dinh dưỡng y học, kể cả thực phẩm dùng
cho chế độ ăn đặc biệt.
- Thông tư này không áp dụng đối với sản phẩm dinh dưỡng công thức dùng cho trẻ
nhỏ. Việc sản xuất, kinh doanh, công bố sản phẩm, ghi nhãn và hướng dẫn sử dụng sản phẩm này được thực hiện theo quy chuẩn kỹ thuật tương ứng và quy định của pháp luật
về kinh doanh và sử dụng các sản phẩm dinh dưỡng dùng cho trẻ nhỏ
Trình bày những cập nhật, sửa đổi về quy định của pháp luật trong ngành dược, bao gồm:
+ Quy định về đăng ký thuốc, ghi nhãn thuốc, thuốc gia công, chuyển giao công tại Việt Nam.
+ Quy định kê đơn thuốc bằng hình thức điện tử
+ Quy định về hoạt động dược lâm sàng
+ Quy định về quản lý chất lượng thuốc
Căn cứ vào công văn số 2098/BYT-TB-CT ngày 12/04/2023 của Bộ Y tế đề nghị các cơ sở đã thực hiện Công bố hồ sơ Trang thiết bị y tế trên Hệ thống dịch vụ công trực tuyến về quản lý thiết bị y tế (https://dmec.moh.gov.vn) tổ chức rà soát các nội dung theo quy định đối với các thủ tục sau:
- thủ tục đủ điều kiện sản xuất trang thiết bị y tế
- thủ tục công bố đủ điều kiện mua bán trang thiết bị y tế thuộc loại B, C, D
- thủ tục công bố tiêu chuẩn áp dụng đối với trang thiết bị y tế thuộc loại A, B:
Xác nhận lại thông tin về tiêu chuẩn áp dụng và đảm bảo rằng chúng đáp ứng đúng yêu cầu.
Thu hồi số công bố nếu phát hiện không tuân thủ đúng tiêu chuẩn áp dụng.
1. Nghị định này quy định chi tiết một số điều của Luật Khám bệnh, chữa bệnh về:
a) Cấp giấy phép hành nghề khám bệnh, chữa bệnh;
b) Cấp giấy phép hoạt động khám bệnh, chữa bệnh;
c) Áp dụng kỹ thuật mới, phương pháp mới và thử nghiệm lâm sàng trong khám bệnh, chữa bệnh;
d) Quản lý thiết bị y tế tại cơ sở khám bệnh, chữa bệnh;
đ) Huy động, điều động cơ sở khám bệnh, chữa bệnh tham gia hoạt động khám bệnh, chữa bệnh trong trường hợp xảy ra thiên tai, thảm họa, dịch bệnh truyền nhiễm thuộc nhóm A và tình trạng khẩn cấp;
e) Điều kiện bảo đảm cho hoạt động khám bệnh, chữa bệnh;
g) Hướng dẫn các quy định về lộ trình thực hiện; quy định chuyển tiếp liên quan đến giấy phép hành nghề và giấy phép hoạt động.
Nghị định này quy định về Chứng chỉ hành nghề dược; kinh doanh
dược; xuất khẩu, nhập khẩu thuốc; đăng ký lưu hành dược liệu, tá dược, vỏ
nang; đánh giá cơ sở sản xuất thuốc tại nước ngoài; thẩm quyền, hình thức,
thủ tục thu hồi nguyên liệu làm thuốc, biện pháp xử lý nguyên liệu làm thuốc
bị thu hồi; hồ sơ, trình tự thủ tục và thẩm quyền cấp giấy xác nhận nội dung
thông tin, quảng cáo thuốc và biện pháp quản lý giá thuốc.
2. Nghị định này áp dụng đối với cơ quan, tổ chức, cá nhân trong nước
và nước ngoài có hoạt động liên quan đến dược tại Việt Nam.
Decree 154/2018/ND-CP issued Hanoi, November 09, 2018: Amending, supplementing and repealing certain articles of the Government on investment and business conditions in sectors under management of ministry of science and technology and certain regulations on specialized inspections
This Decree prescribes conditions for provision of conformity assessment services in Vietnam, including conditions for organizations to assess conformity of products and goods, production or service provision processes and environment with announced applicable standards or relevant technical regulations, and conditions for organizations to accredit conformity assessment organizations.
Nghị định này quy định về điều kiện kinh doanh dịch vụ đánh giá sự phù hợp tại Việt Nam gồm: Tổ chức đánh giá sự phù hợp đối với sản phẩm, hàng hóa, quá trình sản xuất, cung ứng dịch vụ, môi trường phù hợp với tiêu chuẩn công bố áp dụng, quy chuẩn kỹ thuật tương ứng và tổ chức công nhận tổ chức đánh giá sự phù hợp.
Ngày 04/10/2021, Thủ tướng Chính phủ đã phê duyệt Quyết định số 1661/QĐ-TTg, về phương án cắt giảm và đơn giản hóa các quy định liên quan đến hoạt động kinh doanh thuộc phạm vi quản lý của Bộ Y tế. Quyết định này bao gồm tổng cộng 153 quy định về thủ tục hành chính và 14 quy định về điều kiện kinh doanh.
Theo đó, chính sách này thực hiện quan điểm nhằm tạo điều kiện thuận lợi nhất cho doanh nghiệp và người dân tham gia hoạt động kinh doanh. Mục tiêu là giảm thiểu thời gian và chi phí cho doanh nghiệp và người dân trong việc tuân thủ các quy định liên quan đến hoạt động kinh doanh. Đồng thời, chính phủ cũng hướng tới việc cắt giảm và đơn giản hóa các quy định không cần thiết, không hợp lý, không hợp pháp, cái mà thường tạo rào cản và gây khó khăn cho hoạt động kinh doanh của doanh nghiệp và người dân. Chính sách này được xem là một bước quan trọng nhằm nâng cao hiệu lực, hiệu quả và đảm bảo mục tiêu quản lý nhà nước, đồng thời thúc đẩy sự phát triển của doanh nghiệp.
Ngày 30 tháng 12 năm 2023, Bộ Y Tế ban hành Công văn số 8329/BYT-HTTB- kiểm tra, rà soát thủ tục công bố trang thiết bị y tế, gửi Sở Y Tế tỉnh, thành phố trực thuộc trung ương đề nghị Sở Y Tế khẩn trương thực hiện các nội dung sau:
- Thực hiện rà soát lại các hồ sơ công bố trang thiết bị y tế trên Hệ thống https://dmec.moh.gov.vn theo đúng quy định và các văn bản liên quan (lưu ý rà soát kết quả phân loại trang thiết bị y tế bảo đảm theo đúng quy định về phân loại trang thiết bị y tế);
- Kiểm tra về tính hợp pháp, chính xác của các giấy tờ, tài liệu đã nộp trong hồ sơ và bảo đảm các giấy tờ, tài liệu của hồ sơ luôn còn hiệu lực trong suốt quá trình thực hiện, đồng thời chịu trách nhiệm lưu giữ các giấy tờ, tài liệu trong hồ sơ đã nộp theo quy định
Ngày 02 tháng 01 năm 2024, Bộ y tế ban hành quyết định số 04/QĐ-BYT- Về việc chỉ định đơn vị thẩm định hồ sơ kỹ thuật chung về trang thiết bị y tế theo quy định của ASEAN.
- Quyết định gồm các nội dung sau:
1. Chỉ định các đơn vị tiến hành thẩm định hồ sơ kỹ thuật chung về TTBYT theo quy định của ASEAN
+ Đối với hồ sơ đề nghị cấp số lưu hành TTBYT không phải trang thiết bị y tế chẩn đoán in vitro: Viện Trang thiết bị và Công trình y tế
+ Đối với hồ sơ đề nghị cấp số lưu hành TTBYT chẩn đoán in vitro : Viện Kiểm định Quốc gia Vắc xin và Sinh phẩm y tế
2. Hiệu lực thi hành của Quyết định: Ngày 02 tháng 01 năm 2024
Thông tư này hướng dẫn nội dung, cách ghi thành phần dinh dưỡng, giá trị dinh dưỡng và lộ trình thực hiện đối với thực phẩm bao gói sẵn được sản xuất, kinh doanh, nhập khẩu, lưu thông tại Việt Nam.
This Circular provides guidance on contents and presentation of nutrients and their values (hereinafter referred to as "nutrition facts") on food labels, and the roadmap for implementation with regard to prepackaged foods that are manufactured, sold, imported into, circulated in Vietnam.
1. Thông tư này quy định Danh mục chất cấm sử dụng trong sản xuất, kinh doanh thực phẩm bảo vệ sức khỏe.
2. Thông tư này áp dụng đối với tổ chức, cá nhân Việt Nam; tổ chức, cá nhân nước ngoài tại Việt Nam tham gia sản xuất, kinh doanh thực phẩm bảo vệ sức khỏe; tổ chức, cá nhân có hoạt động liên quan đến thực phẩm bảo vệ sức khỏe tại Việt Nam.
Ngày 03/3/2023, Chính phủ ban hành Nghị định 07/2023/NĐ-CP sửa đổi Nghị định 98/2021/NĐ-CP về quản lý trang thiết bị y tế.
Theo đó, nội dung niêm yết giá trang thiết bị y tế được quy định như sau:
- Tổ chức, cá nhân sản xuất, kinh doanh trang thiết bị y tế thực hiện niêm yết giá trang thiết bị y tế tại các địa điểm theo quy định tại Điều 17 Nghị định 177/2013/NĐ-CP hướng dẫn Luật Giá hoặc trên Cổng thông tin điện tử của Bộ Y tế.
- Trường hợp niêm yết giá trang thiết bị y tế trên Cổng thông tin điện tử của Bộ Y tế phải có đầy đủ các thông tin tối thiểu sau:
+ Tên, chủng loại trang thiết bị y tế.
+ Hãng, nước sản xuất; hãng, nước chủ sở hữu.
+ Đơn vị tính.
+ Cấu hình, tính năng kỹ thuật của trang thiết bị y tế.
+ Giá niêm yết của trang thiết bị y tế.
Thông tư 19/2021/TT-BYT ban hành ngày 16 tháng 11 năm 2021: quy định các mẫu văn bản, báo cáo thực hiện Nghị định số 98/2021/NĐ-CP ngày 08 tháng 11 năm 2021 của Chính phủ về quản lý trang thiết bị y tế.
Quyết định 2426/QD-BYT Ban hành kèm theo Mẫu hồ sơ kỹ thuật chung về trang thiết bị y tế theo quy định của ASEAN, áp dụng trong hồ sơ đề nghị cấp số lưu hành cho các trang thiết bị y tế loại B, C, D.
Thông tư 10/2023/TT-BYT: Sửa đổi, bổ sung Điều 3 Thông tư số 19/2021/TT-BYT ngày 16 tháng 11 năm 2021 của Bộ trưởng Bộ Y tế quy định mẫu văn bản, báo cáo thực hiện Nghị định số 98/2021/NĐ-CP ngày 08 tháng 11 năm 2021 của Chính phủ về quản lý trang thiết bị y tế
More from MedGate Vietnam| Regulatory Affairs of Pharmaceutical, Medical Devices, Cosmetic (20)
हम आग्रह करते हैं कि जो भी सत्ता में आए, वह संविधान का पालन करे, उसकी रक्षा करे और उसे बनाए रखे।" प्रस्ताव में कुल तीन प्रमुख हस्तक्षेप और उनके तंत्र भी प्रस्तुत किए गए। पहला हस्तक्षेप स्वतंत्र मीडिया को प्रोत्साहित करके, वास्तविकता पर आधारित काउंटर नैरेटिव का निर्माण करके और सत्तारूढ़ सरकार द्वारा नियोजित मनोवैज्ञानिक हेरफेर की रणनीति का मुकाबला करके लोगों द्वारा निर्धारित कथा को बनाए रखना और उस पर कार्यकरना था।
31052024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
In a May 9, 2024 paper, Juri Opitz from the University of Zurich, along with Shira Wein and Nathan Schneider form Georgetown University, discussed the importance of linguistic expertise in natural language processing (NLP) in an era dominated by large language models (LLMs).
The authors explained that while machine translation (MT) previously relied heavily on linguists, the landscape has shifted. “Linguistics is no longer front and center in the way we build NLP systems,” they said. With the emergence of LLMs, which can generate fluent text without the need for specialized modules to handle grammar or semantic coherence, the need for linguistic expertise in NLP is being questioned.
role of women and girls in various terror groupssadiakorobi2
Women have three distinct types of involvement: direct involvement in terrorist acts; enabling of others to commit such acts; and facilitating the disengagement of others from violent or extremist groups.
‘वोटर्स विल मस्ट प्रीवेल’ (मतदाताओं को जीतना होगा) अभियान द्वारा जारी हेल्पलाइन नंबर, 4 जून को सुबह 7 बजे से दोपहर 12 बजे तक मतगणना प्रक्रिया में कहीं भी किसी भी तरह के उल्लंघन की रिपोर्ट करने के लिए खुला रहेगा।
03062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
01062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
Decision 04/QĐ-BYT: The Designation of Units for Assessment of The Common Technical Dossier on Medical Devices According to The ASEAN Regulations
1. MINISTRY OF HEALTH OF
VIETNAM
-------
SOCIALIST REPUBLIC OF VIETNAM
Independence - Freedom - Happiness
---------------
No. 04/QĐ-BYT Ha Noi, 2 January, 2021
DECISION
The Designation of Units for Assessment of The Common Technical Dossier on
Medical Devices According to The ASEAN Regulations
MINISTRY OF HEALTH OF VIETNAM
Pursuant to Decree No. 95/2022/ND-CP dated November 15, 2022 of the Government on
functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;
Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on
management of medical devices;
Pursuant to Decree No. 07/2023/ND-CP dated March 03, 2023 of the Government on
amendments to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on
management of medical devices;
Pursuant to Decision No. 2426/QĐ-BYT dated May 15, 2021 on promulgation of guidance on
the preparation of Asean common submission dossier for medical devices
Pursuant to Decision No. 5319/QĐ-BYT dated November 8, 2019, on promulgation of the
Regulations on the Organization and Operation of the Institute of Medical Device and Health
Works;
Pursuant to Decision No. 2028/QĐ-BYT dated July 25, 2022, on promulgation of the
Regulations on the Organization and Operation of the National Testing Institute for Vaccine
and Biological Products;
In accordance with the proposal of the Director of the Department of Infrastructure and Medical
Device.
DECISION:
Article 1. Designate the units responsible for assessing The Common Technical Dossier for
medical devices according to ASEAN regulations (hereinafter referred to as CSDT
documentation), specifically:
- The Institute of Medical Device and Health Works shall organize the assessment and provide
assessment results for CSDT documentation for applications for the circulation permit of
medical devices that are not in vitro diagnostic medical devices, as regulated.
- The National Testing Institute for Vaccine and Biological Products shall organize the
assessment and provide assessment results for CSDT documentation for applications for the
circulation permit of in vitro diagnostic medical devices, as regulated.
Article 2. Responsibilities of the designated unit:
MEDGATE TECHNOLOGY AND
INVESTMENT JOINT STOCK COMPANY
Hotline: 098.546.1894
Website: medgate.vn
2. 1.The unit designated to assess the CSDT documentation as stipulated in Article 1 of this
Decision shall be responsible for:
- Coordinating with the Ministry of Health (Department of Infrastructure and Medical Device)
during the processing of applications for the circulation permit of medical devices and
maintaining CSDT documentation as required.
- Reporting the results of periodic assessments of CSDT documentation to the Ministry of
Health (Department of Infrastructure and Medical Device) every 6 months and 1 year.
2.In case of difficulties or obstacles during the implementation, the designated unit for assessing
CSDT documentation as specified in Article 1 of this Decision should contact the Ministry of
Health (Department of Infrastructure and Medical Equipment) for review and resolution.
Article 3. This Decision shall take effect from the date of signing.
Article 4. Individuals responsible for the implementation of this Decision include: Secretary of
the Ministry, Chief Inspector of the Ministry, Director of the Department of Infrastructure and
Medical Equipment, Heads of the Organization and Personnel Department, Heads of the
Planning and Finance Department, Director of the Institute of Medical Equipment and
Construction, Director of the National Institute for Vaccine and Biological Products Testing,
and Heads of relevant organizations and individuals.
PP. MINISTER
DEPUTY MINISTER
Do Xuan Tuyen
